The scientists in the cluster have access to state-of-the-art research infrastructure. Many of the facilities were established during the previous funding phase of the Excellence Initiative in the predecessor cluster "Inflammation at Interfaces", and some are still under construction. A key focus of the cluster is on sequencing technologies and large biobanks. But there are also state-of-the-art facilities for stem cell research and imaging.
Founded in 2009, the Comprehensive Centers for Inflammation Medicine (CCIM) are large outpatient clinics for inflammatory diseases at the University Medical Center Schleswig-Holstein in Kiel and Lübeck. Through close cooperation between different specialists, they enable the best possible patient care. The goal of the centers is to facilitate interdisciplinary treatment of patients with serious chronic inflammatory diseases as efficiently and quickly as possible.
The CCIMs are also responsible for the creation and characterization of clinical cohorts for research purposes, and provide access to new treatments and diagnostic approaches, most of which have been developed in the predecessor cluster "Inflammation at Interfaces".
The cluster’s Sequencing Center is specialized in so-called "Next Generation Sequencing", i.e. a state-of-the-art, high-resolution sequencing process for ultra-high throughput. Using this technology, several hundred patient genomes can be decoded within a short period of time, for example. The Kiel Sequencing Center is one of the largest of its kind in Germany. The cluster’s Sequencing Center is affiliated with the „Competence Centre for Genome Analysis Kiel“ (CCGA Kiel) in the Centre for Molecular Biosciences (ZMB) (LINK). The CCGA is one of four German competence centers for next generation sequencing, funded by the German Research Foundation (DFG).
The heads and staff at the Sequencing Center use their combined expertise to advise colleagues on new research projects, and assist with the analysis of the resulting huge volumes of data.
The universities in Kiel and Lübeck possess highly-standardized, comprehensive biobank infrastructures, which support a variety of research projects. The main biobank activities in Kiel as well as in the Research Center Borstel take place under the organizational leadership of the PopGen 2.0 Netzwerks (P2N). The biobank activities in Lübeck are coordinated by the Interdisciplinary Center for Biobanking - Lübeck (ICB-L).
The PopGen biobank is an important resource for the Cluster of Excellence. It contains more than 500,000 samples and data from around 70,000 patients with various diseases as well as control groups which are representative of the population. The infrastructures of PopGen meet the highest quality, data privacy and security standards, and thus enjoy great confidence among the ranks of the cluster researchers. Thus, the PopGen biobank and the PopGen 2.0 Network (P2N) are central prerequisites for excellent clinical research in PMI.
The PopGen biobank and the Institute of Epidemiology are also involved in the implementation of the NAKO health study, the largest nationwide population study to date. The PopGen biobank and the Institute of Epidemiology oversee NAKO study research in Schleswig-Holstein, in which a total of 9,500 people from Schleswig-Holstein are comprehensively medically examined and interviewed, and relevant biological samples are also collected. Throughout Germany, 200,000 people between the ages of 18 and 69 are involved in the NAKO health study, and are supervised by the responsible study center for around 30 years, i.e. regularly interviewed and examined.
The ZMB is a prestigious new building on the Kiel University campus, whose concept is determined by interdisciplinary and scientific interaction. The combination of research groups from the Faculties of Medicine, Mathematics and Natural Sciences, and Agricultural and Nutritional Sciences at Kiel University were the basis for the new ZMB building. The ZMB hosts the essential platforms and infrastructures of the Cluster of Excellence PMI, e.g. the PopGen biobank samples and the Competence Centre for Genome Analysis Kiel (CCGA Kiel). The operation of these platforms is the responsibility of the Institute of Clinical Molecular Biology (IKMB).
The National Reference Center for Mycobacteria at the Research Center Borstel, appointed by the Federal Ministry of Health and the Robert Koch Institute, is involved in coordinating measures in the fight against and monitoring of tuberculosis (TB).
The tasks include analysis of approximately 15,000 samples per year, for the detection and identification of mycobacteria as well as sensitivity testing, the development, improvement and evaluation of new techniques for faster diagnosis of TB, as well as "DNA fingerprinting" for the detection of infection chains. The center handles more than 3000 inquiries per year for the diagnosis and therapy of mycobacterioses and is also internationally networked as the Supranational Reference Centre for Mycobacteria of the World Health Organisations. Thus, in recent years, one of the world's most extensive genetic databases for tuberculosis bacteria has been developed in Borstel.
The Molecular Imaging North Competence Center (MOIN CC) at Kiel University provides a technology and cooperation platform for researchers and companies in the life science sector. One of the focal points is molecular imaging, which is regarded as one of the most dynamic innovation and growth areas in the field of biomedical engineering.
The MOIN CC is operated by the Departments of Biomedical Imaging, Radiology and Neuroradiology at the University Medical Center Schleswig-Holstein (UKSH). The laboratory was primarily established as a central unit for academic users. However, through "MOIN Services", it also provides imaging services for the private sector and biomedical companies in Northern Germany and beyond.